Compare KALA & DUOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KALA | DUOT |
|---|---|---|
| Founded | 2009 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 172.0M | 244.3M |
| IPO Year | 2017 | 2017 |
| Metric | KALA | DUOT |
|---|---|---|
| Price | $2.25 | $13.43 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $31.50 | $17.00 |
| AVG Volume (30 Days) | ★ 1.2M | 782.9K |
| Earning Date | 04-15-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 67.39 | 53.96 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $27,023,651.00 |
| Revenue This Year | N/A | $50.98 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 271.16 |
| 52 Week Low | $0.07 | $5.78 |
| 52 Week High | $20.58 | $15.28 |
| Indicator | KALA | DUOT |
|---|---|---|
| Relative Strength Index (RSI) | 59.31 | 67.84 |
| Support Level | $0.32 | $8.12 |
| Resistance Level | $3.96 | N/A |
| Average True Range (ATR) | 0.37 | 1.13 |
| MACD | -0.07 | 0.55 |
| Stochastic Oscillator | 7.27 | 73.45 |
Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.
Duos Technologies Group Inc delivers AI-driven technologies, edge computing infrastructure, and energy consulting services to support data-intensive and mission-critical operations. It manages, operates, engineers, software development, customer support and project implementation and management across three market segments, including rail technology deployment, Data Center co-location facilities, and behind-the-meter electrical power provision. It also continues to operate as a technology company which designs, develops, deploys, and operates intelligent technology solutions with a focus on software applications and artificial intelligence (AI) in addition to large projects, consulting, implementation, and asset management.